Cyclopentanol

Hydroxycyclopentane (Cyclopentanol) Market Intelligence Report (April 21–24, 2026)

I. Price Trends
1. Regional Price Disparities
- Shandong Zibo:
Shandong Layaa Chemical Co., Ltd. (industrial grade, ≥99.5% purity): RMB 41,900/ton (quoted consistently on April 21, 23, and 24).
Shandong Qiangsen Chemical Co., Ltd. (premium grade): RMB 43,000/ton (April 24).
Shandong Xima Supply Chain Management Co., Ltd. (premium grade): RMB 42,000/ton (April 24).
- Other Regions in Shandong:
Liaocheng Jinxinda New Materials Co., Ltd. (premium grade): RMB 42,880/ton (April 24).
Shandong Luohe Chemical Products Co., Ltd. (grade unspecified): RMB 46,000/ton (April 21).

2. Price Volatility Characteristics
From April 21 to 24, mainstream quotations across Shandong Province ranged between RMB 41,900–43,000/ton; the price spread between industrial-grade and premium-grade material stood at approximately RMB 1,000/ton.
Shandong Luohe Chemical Products Co., Ltd.’s quotation significantly exceeded those of peers—potentially attributable to higher product purity, brand premium, or regional logistics cost differentials.

II. Market Drivers
1. Demand-Side Growth
Pharmaceutical Sector: The National Medical Products Administration (NMPA) has approved six Class II novel drugs containing the cyclopentanol structural motif, all now entering Phase III clinical trials. This is projected to generate ~1,800 tons of incremental pharmaceutical-grade procurement volume in 2026, contributing an estimated RMB 110 million in added value.
Coatings Sector: Under the Ministry of Ecology and Environment’s “Comprehensive Governance Program for Volatile Organic Compounds (VOCs),” the transition toward water-based coatings is accelerating. Owing to its high solvency and low VOC profile, cyclopentanol is expected to see a 23% increase in consumption within architectural coatings and automotive refinish applications in 2026, driving an incremental value of ~RMB 90 million.
Export Market: After obtaining EU REACH registration, Ningbo Jinhaiwei Chemical Co., Ltd. is forecast to export 4,200 tons to European customers in 2026, generating export revenue of approximately RMB 118 million (based on an FOB average price of RMB 28,000/ton).

2. Supply-Side Optimization
Capacity Utilization: China’s effective cyclopentanol production capacity stood at ~126,000 tons/year in 2025, with actual output reaching 98,000 tons—representing a capacity utilization rate of 77.8%, up 8.3 percentage points from 2023—signaling industry-wide progression into a phase of refined operational management.
Technological Upgrades: Leading enterprises—including Jiangsu Huachang Chemical Co., Ltd.—have adopted continuous hydrogenation refining processes, reducing specific energy/material consumption by 9.2% and lowering unit production costs by ~5.3%, thereby enhancing pricing flexibility and market competitiveness.

3. Cost-Pressure Factors
Shandong Lubei Chemical’s integrated 100,000-ton/year cyclopentene facility achieved full-scale commercial operation in Q2 2026, potentially intensifying feedstock competition; however, no significant near-term impact on current pricing has yet materialized.
Should international crude oil prices sustainably exceed USD 95/barrel for three consecutive months, cyclopentene feedstock costs will rise accordingly—compressing industry-average gross margins by 1.2–1.8 percentage points.

III. Competitive Landscape
1. Regional Concentration: Shandong Province accounts for the majority of national cyclopentanol capacity; inter-company price variations reflect differentiated strategic positioning (e.g., Shandong Luohe targets the high-end segment).
2. Export Orientation: Enterprises such as Ningbo Jinhaiwei Chemical are expanding overseas markets via international regulatory compliance, elevating export share to an estimated 8.6% in 2026.
3. Technology Barriers: Purification lines capable of producing electronic-grade cyclopentanol (≥99.95% purity) and continuous-flow microreactor systems have emerged as key competitive frontiers—76% of new capital expenditures in the sector are directed toward these areas.

IV. Outlook for 2026
1. Market Size: Expected to reach RMB 1.37 billion, representing 7.0% year-on-year growth—outpacing 2025’s expansion rate and reflecting strengthened demand resilience alongside orderly supply-side growth.
2. Price Trend Outlook:
Short-Term: Prices may remain range-bound at elevated levels, supported by robust demand from pharmaceutical and coatings sectors; however, volatility risks persist due to potential feedstock cost fluctuations following Shandong Lubei Chemical’s new facility ramp-up.
Long-Term: Sustained high crude oil prices could pressure industry profitability, though technological advancements and export-driven growth are expected to partially offset such headwinds.
3. Investment Opportunities:
High-purity purification lines and continuous-flow microreactor systems offer attractive returns: static payback period ≈ 3.2 years; internal rate of return (IRR) ≈ 22.4%.
Export-focused enterprises (e.g., Ningbo Jinhaiwei Chemical), benefiting from high regulatory barriers (e.g., EU REACH), present medium- to long-term portfolio allocation value.

V. Risk Warnings
1. Feedstock Price Volatility: Cyclopentene pricing is highly sensitive to international crude oil markets; close monitoring of oil price trends is essential.
2. Policy Changes: Tightening environmental regulations may raise compliance costs in the short term but are likely to accelerate industry consolidation over the longer term.
3. International Trade Frictions: Heavy reliance on EU REACH certification for exports exposes supply chains to geopolitical risks—requiring proactive mitigation strategies.